Journal of Community Health

, Volume 43, Issue 5, pp 937–943 | Cite as

Pertussis and the Minnesota State Fair: Demonstrating a Novel Setting for Efficiently Conducting Seroepidemiologic Studies

  • Erinn Sanstead
  • Nicole E. Basta
  • Karen Martin
  • Victor Cruz
  • Kristen Ehresmann
  • Shalini Kulasingam
Original Paper


Seroepidemiologic studies, which measure serum antibody levels produced in response to infection and/or vaccination, can be valuable tools for gaining insight into population level dynamics of infectious diseases. However, because seroepidemiologic studies are expensive and logistically challenging, they are not routinely conducted for surveillance purposes. We have identified a novel venue, state fairgrounds, in which annual sera samples from a population may be rapidly collected with minimal recruitment expenses. We conducted a pilot pertussis seroepidemiologic study over the course of 3 days at the 2016 Minnesota State Fair to determine if this setting, which hosts nearly 2 million visitors over 12 days each year, is viable for facilitating larger seroepidemiologic studies. A total of 104 adults and children were enrolled to provide a finger stick blood sample for serologic testing and to take a written survey regarding recent cough illness and pertussis vaccination. The survey was used to distinguish between antibodies induced by vaccination and pertussis infection. Elevated antibodies suggestive of recent infection were found among two adults. The prevalence of undetectable antibodies, suggestive of susceptibility, was 72.3% (95% CI 59.6, 85.1%) among 7–17 year olds, 53.8% (95% CI 26.7, 80.9%) among 1–6 year olds, and 23.3% (95% CI 8.2, 38.5%) among adults. Our ability to rapidly enroll participants and collect satisfactory specimens suggests that seroepidemiologic studies with 1000–2000 participants could efficiently be completed over the 12-day course of the Minnesota State Fair. This setting raises the possibility of efficiently conducting annual population-based seroepidemiologic studies to supplement traditional public health surveillance in estimating disease prevalence, monitoring vaccine impact, and identifying at-risk groups.


Serology Infectious diseases Vaccination Pertussis 



This study was funded by a Clinical and Translational Science Institute Driven to Discover Community Health Research Grant and a J.B. Hawley Student Research Award from the University of Minnesota School of Public Health.

Compliance with Ethical Standards

Conflict of interest

The authors declare that they have no conflict of interest.

Research Involving Human Participants

All procedures performed in this study involving human participants were in accordance with the ethical standards of the University of Minnesota and the Minnesota Department of Health Institutional Review Boards and with the 1964 Helsinki declaration.

Informed Consent

Written informed consent was obtained from study participants aged 18 years or older and from guardians of participants under the age of 18 years. Written informed assent was obtained from participants aged 7–17 years.


  1. 1.
    Metcalf, J. E., Farrar, J., Cutts, F. T., et al. (2016). Use of serological surveys to generate key insights into the changing global landscape of infectious disease. The Lancet, 388(10045), 728–730. Scholar
  2. 2.
    Cagney, M., McIntyre, P. B., Heron, L., Giammanco, A., & MacIntyre, C. R. (2008). The relationship between pertussis symptomatology, incidence and serology in adolescents. Vaccine, 26(44), 5547–5553. Scholar
  3. 3.
    McNamara, L. A., Skoff, T., Faulkner, A., et al. (2017). Reduced severity of pertussis in persons with age-appropriate pertussis vaccination-United States, 2010-2012milder pertussis in vaccinated people. Clinical Infectious Diseases, 65(5), 811–818. Scholar
  4. 4.
    Althouse, B. M., & Scarpino, S. V. (2015). Asymptomatic transmission and the resurgence of Bordetella pertussis. BMC Medicine, 13(1), 146. Scholar
  5. 5.
    CDC. (2016). Pertussis: Surveillance and reporting. Washington, DC: Centers for Disease Control and Prevention. Retrieved June 6, 2016, from
  6. 6.
    Baptista, P. N., Magalhaes, V. S., & Rodrigues, L. C. (2010). The role of adults in household outbreaks of pertussis. International Journal of Infectious Diseases, 14(2), 0–3. Scholar
  7. 7.
    Deville, J. G., Cherry, J. D., Christenson, P. D., et al. (1995). Frequency of unrecognized Bordetella pertussis infections in adults. Clinical Infectious Diseases, 21(3), 639–642.CrossRefPubMedGoogle Scholar
  8. 8.
    Koh, M. T., Liu, C. -S., Chiu, C. -H., et al. (2016). Under-recognized pertussis in adults from Asian countries: A cross-sectional seroprevalence study in Malaysia, Taiwan and Thailand. Epidemiology and Infection, 144(6), 1192–1200. Scholar
  9. 9.
    Jõgi, P., Oona, M., Toompere, K., Leedo, S., Epstein, J., & Lutsar, I. (2014). Seroprevalence of IgG antibodies to pertussis toxin in children and adolescents in Estonia. Vaccine, 32(41), 5311–5315. Scholar
  10. 10.
    Lavine, J. S., King, A. A., & Bjørnstad, O. N. (2011). Natural immune boosting in pertussis dynamics and the potential for long-term vaccine failure. Proceedings of the National Academy of Sciences USA, 108(17), 7259–7264. Scholar
  11. 11.
    Tartof, S. Y., Lewis, M., Kenyon, C., et al. (2013). Waning immunity to pertussis following 5 doses of DTaP. Pediatrics, 131(4), e1047–e1052. Scholar
  12. 12.
    Wang, C. -Q., & Zhu, Q. -R. (2011). Seroprevalence of Bordetella pertussis antibody in children and adolescents in China. The Pediatric Infectious Disease Journal, 30(7), 593–596. Scholar
  13. 13.
    Campbell, P., McIntyre, P., Quinn, H., Hueston, L., Gilbert, G. L., & McVernon, J. (2012). Increased population prevalence of low pertussis toxin antibody levels in young children preceding a record pertussis epidemic in Australia. PLoS ONE. Scholar
  14. 14.
    Cutts, F. T., & Hanson, M. (2016). Seroepidemiology: An underused tool for designing and monitoring vaccination programmes in low- and middle-income countries. Tropical Medicine and International Health, 21(9), 1086–1098. Scholar
  15. 15.
    Kelly, H., Riddell, M. A., Gidding, H. F., Nolan, T., & Gilbert, G. L. (2002). A random cluster survey and a convenience sample give comparable estimates of immunity to vaccine preventable diseases in children of school age in Victoria, Australia. Vaccine, 20(25–26), 3130–3136. Scholar
  16. 16.
    Wilson, S. E., Deeks, S. L., Hatchette, T. F., & Crowcroft, N. S. (2012). The role of seroepidemiology in the comprehensive surveillance of vaccine-preventable diseases. CMAJ, 184(1), 70–76. Scholar
  17. 17.
    Centers for Disease Control and Prevention. (2017). National health and nutrition examination survey overview. Retrieved from Accessed 1 Feb 2018.
  18. 18.
    Rohani, P., & Drake, J. M. (2011). The decline and resurgence of pertussis in the US. Epidemics, 3(3–4), 183–188. Scholar
  19. 19.
    Magpantay, F. M. G., & Rohani, P. (2015). Dynamics of pertussis transmission in the United States. American Journal of Epidemiology, 181(12), 921–931. Scholar
  20. 20.
    Minnesota State Fair. (2015). Demographics sheet. Retrieved October 17, 2015, from
  21. 21.
    Minnesota State Fair. (2016). Minnesota state fair attendance. Retrieved October 17, 2016, from
  22. 22.
    CDC. (2015). Pertussis: Summary of vaccine recommendations. Retrieved June 6, 2016, from
  23. 23.
    Misegades, L. K., Winter, K., Harriman, K., et al. (2012). Association of childhood pertussis with receipt of 5 doses of pertussis vaccine by time since last vaccine dose, California, 2010. JAMA, 308(20), 2126–2132. Scholar
  24. 24.
    Klein, N. P., Bartlett, J., Rowhani-Rahbar, A., Fireman, B., & Baxter, R. (2012). Waning protection after fifth dose of acellular pertussis vaccine in children. New England Journal of Medicine, 367(11), 1012–1019. Scholar
  25. 25.
    Menzies, S. L., Kadwad, V., Pawloski, L. C., et al. (2009). Development and analytical validation of an immunoassay for quantifying serum anti-pertussis toxin antibodies resulting from Bordetella pertussis infection. Clinical and Vaccine Immunology, 16(12), 1781–1788. Scholar
  26. 26.
    Barkoff, A.-M., Grondahl-Yli-Hannuksela, K., & He, Q. (2015). Seroprevalence studies of pertussis: What have we learned from different immunized populations. Pathogens and Disease, 73(7), 1–12. Scholar
  27. 27.
    CDC. (2016). Pertussis/whooping cough 2010 case definition. Retrieved July 19, 2016, from
  28. 28.
    Hallander, H. O., Andersson, M., Gustafsson, L., Ljungman, M., & Netterlid, E. (2009). Seroprevalence of pertussis antitoxin (anti-PT) in Sweden before and 10 years after the introduction of a universal childhood pertussis vaccination program. APMIS, 117(12), 912–922. Scholar
  29. 29.
    Altizer, S., Dobson, A., Hosseini, P., Hudson, P., Pascual, M., & Rohani, P. (2006). Seasonality and the dynamics of infectious diseases. Ecology Letters, 9(4), 467–484. Scholar
  30. 30.
    Miller, E., Hoschler, K., Hardelid, P., Stanford, E., Andrews, N., & Zambon, M. (2010). Incidence of 2009 pandemic influenza A H1N1 infection in England: A cross-sectional serological study. The Lancet, 375(9720), 1100–1108. Scholar
  31. 31.
    Brown, H. (2017). How does Minnesota’s State Fair stack up agains the rest? CBS Minnesota. Retrieved December 20, 2017, from

Copyright information

© Springer Science+Business Media, LLC, part of Springer Nature 2018

Authors and Affiliations

  1. 1.Division of Epidemiology and Community HealthUniversity of Minnesota School of Public HealthMinneapolisUSA
  2. 2.Division of Infectious Disease Epidemiology, Prevention and ControlMinnesota Department of HealthSt. PaulUSA

Personalised recommendations